Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Federico Grossi
Age : 46
Public asset : 6,346,531 USD
Country of residence : Unknown
Linked companies : Apellis Pharmaceuticals, Inc.

Biography of Federico Grossi 
Federico Grossi occupies the position of Chief Medical Officer for Apellis Pharmaceuticals, Inc. He is also on the board of Endoprotech, Inc. In the past Dr. Grossi was Director-Clinical Research at Potentia Pharmaceuticals, Inc., Executive Vice President for Potentia Pharmaceuticals, Inc. and Member-Face Transplant Team at the University of Louisville. He received a graduate degree and a doctorate from the University of Louisville and a doctorate from National University of Cordoba.


Current positions of Federico Grossi 
Holdings of Federico Grossi 
Federico Grossi : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Federico Grossi : Connections 


Latest news about Federico Grossi 
09/02Insider Sell: Apellis Pharmaceuticals
MT
08/24Transcript : Apellis Pharmaceuticals, Inc. - Special Call
CI
08/08Transcript : Apellis Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 08, 2022
CI
08/02Insider Sell: Apellis Pharmaceuticals
MT
05/04Transcript : Apellis Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Insider Sell: Apellis Pharmaceuticals
MT
03/16Transcript : Apellis Pharmaceuticals, Inc. - Special Call
CI
More news